caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1518129980

Samantha Chai

PRACTICESERRANO EYE CENTER MEDICAL GROUPSee all providers at this practice →
OphthalmologyLos Angeles, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Samantha Chai's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 15 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Unilab Corporation
Clinical Laboratory · West Hills, CA
47101
Primex Clinical Laboratories Inc.
Clinical Laboratory · Van Nuys, CA
3270
Alvarado Eye Surgery Center Llc
Ambulatory Surgical Center · Los Angeles, CA
2855
Young Suh
Anesthesiology · Los Angeles, CA
2542
Andrew Cho
Ophthalmology · Los Angeles, CA
2131
Young-Jik Lee
Internal Medicine · Los Angeles, CA
1840
Edward Rhee
Podiatry · Los Angeles, CA
1526
Jae Yoo
Internal Medicine · Los Angeles, CA
1552
Luke Yoon
Urology · Los Angeles, CA
1417
Jeffrey Sage
Ophthalmology · Los Angeles, CA
1324
Biocorp Clinical Lab Inc
Clinical Laboratory · Whittier, CA
1324
Phillip Ahn
Neurology · Los Angeles, CA
1221
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
364
Beneficiaries
—
Total drug cost
$59K
Distinct drugs
10
Brand share
43.4%
Top prescribed drugs
Latanoprost85 claims
Brimonidine Tartrate48 claims
Dorzolamide Hcl/Timolol Maleat40 claims
Timolol Maleate33 claims
Netarsudil Mesylate31 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.